Pharma Focus Asia

Pharma Articles

Articles on key issues related to the pharma industry from the heads of leading pharmaceutical companies and pharma industry experts across the globe. The pharma industry articles' section focuses on current and emerging issues in areas such as Strategic developments in the pharma industry, pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical manufacturing, biopharmaceuticals, and information technology.

Multi-Target Directed Ligands and Lipidomics Approach for Glioblastoma Drug Discovery

The traditional pharmaceutical approach of designing a diseasesymptomspecific drug has historically proven effective However this methodology often falls short due to the complex and often multifactorial etiology of diseases

Government Investment in AI Capabilities will Cement Singapore’s Position as a Premier Clinical Trial Location

As Asia establishes itself as the global hub for clinical trials Singapore is bolstering its position as the preferred location for these trials to take place The countrys strong RD capabilities talent pool world class healthcare infrastructure and robust regulatory

Revolutionising Drug Discovery and Development with Artificial Intelligence

As the global pharma industry continues its shift towards precision medicine in the quest for targeting undruggable targets research and development activities have experienced a tremendous surge

Pharma Firms Must Come Together, Ensure Access to Antibiotics in Poor Countries to Take on Superbugs

In an era marked by remarkable medical advancements a disquieting paradox is staring at us While many parts of the world face a growing threat of antimicrobial resistance owing to overuse of antibiotics several low and middle income countries

Viksit Bharat@ 2047 envisioned the Indian Pharma Industry

India as a potential hub for pharmaceutical investors to meet the global crisis of drugs
The Indian Pharmaceuticals industry has emerged globally as one of the fastest growing industries The pharmaceutical industry in India is expected to reach Bn by and Bn by The pharmaceutical industry

The Transformative Impact of AI on Regulatory Affairs

Regulatory affairs in the pharmaceutical industry encompass a broad and complex field that is essential for the development approval and postmarketing surveillance of pharmaceutical products This domain acts as the critical nexus between pharmaceutical companies

APAC’s Biopharma Providers’ Role in Pioneering a Healthcare Revolution

Asias healthcare landscape is undergoing a transformative journey grappling with profound challenges in changing demographics persistent health inequities and the rising burden of increased disease prevalence

There’s Finally Hope to Alleviate the Burden of Chronic Diseases

As societies in Asia grow older chronic diseases are becoming more and more prevalent They place serious strain not only on patients but also on caregivers and the healthcare system

The Potential of Cell Free Chromatin Inhibition in Cancer

A comment
Since seminal work by Dr Mitra from Tata Medical Centre has been done on Cellfree chromatin particles that are released upon cell death When cancer cells die the skeletons of mutated cell free

Artificial Intelligence in Oncology

A path to personalised cancer treatment
Cancer is the most prevalent cause of death across the globe According to the World Health Organization there is an estimated increase from the anticipated million cases of cancer in It is predicted that more than million
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024